Pulse Biosciences Growth Metrics (2020-2025) | PLSE

Growth Metrics Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -2.02M-0.76M10.40M
EBITDA Margin (QoQ) -1.34M-0.55M0.07M-0.21M-0.08M
EBIT Margin Growth (1y) 9.90M
EBIT Margin (QoQ) 0.07M-0.21M-0.08M
EBT Margin Growth (1y) 10.40M
EBT Margin (QoQ) 0.07M-0.21M-0.08M
Enterprise Value Growth (1y) 317.75%114.11%123.22%-33.88%-76.31%-87.40%-97.28%-89.36%-45.36%335.22%952.97%1,397.58%517.77%179.27%482.89%53.39%115.90%53.57%10.00%
Enterprise Value Growth (3y) -18.53%5.49%-13.90%1.76%-7.18%15.26%18.57%34.71%93.88%165.27%307.19%
Enterprise Value Growth (5y) 48.46%38.16%32.56%
Enterprise Value (QoQ) 35.19%48.27%122.91%-6.50%-30.71%54.58%-33.98%-66.50%-63.16%-66.67%158.71%72.01%193.43%-19.36%267.95%-29.05%32.65%68.31%-3.17%-0.13%-5.64%20.55%
FCF Margin Growth (1y) 2.29M4.07M9.33M15.74M-1.39M-0.75M9.05M
FCF Margin Growth (5y) 8.04M
FCF Margin (QoQ) -2.49M-5.82M-6.32M16.92M-0.71M-0.55M0.08M-0.21M-0.07M
Gross Margin Growth (1y) 1.45M
Gross Margin (QoQ) -0.00M-0.01M-0.02M
Net Margin Growth (1y) 10.40M
Net Margin (QoQ) 0.07M-0.21M-0.08M
Operating Margin Growth (1y) 9.90M
Operating Margin (QoQ) 0.07M-0.21M-0.08M
Return on Assets Growth (1y) 87.0045.003.00-10.00-34.00-13.0020.0033.0045.004.00
Return on Assets Growth (3y) 99.0036.00
Return on Assets (QoQ) 51.0030.002.004.009.00-11.00-11.00-20.0029.0022.002.00-8.00-12.00
Return on Capital Employed Growth (1y) 118.0052.00-2.00-16.00-49.00-20.0023.0040.0057.006.00
Return on Capital Employed Growth (3y) 126.0038.00
Return on Capital Employed (QoQ) 74.0038.001.005.008.00-17.00-13.00-28.0038.0026.004.00-10.00-14.00
Return on Equity Growth (1y) 87.00367.000.00M-896.0049.00-17.0032.0054.0078.0011.00
Return on Equity Growth (3y) 215.00361.00
Return on Equity (QoQ) -161.00-0.00M0.00M-979.00118.00-17.00-18.00-34.0052.0032.004.00-9.00-15.00